Results 281 to 290 of about 124,550 (291)

N‐of‐1 trials in clinical research: Methodological foundations, statistical approaches and implementation challenges

British Journal of Clinical Pharmacology, EarlyView.
N‐of‐1 trials offer a unique and rigorous methodology for evaluating individualized treatment responses, particularly within the context of personalized medicine. This article provides a comprehensive explanation of the conceptual and methodological underpinnings of N‐of‐1 trials, with particular emphasis on statistical techniques and considerations ...
Marcos Clint Leal De Carvalho, Matheus de Matos Dourado Simões, Ubiratan Cardinalli Adler, Antonio Brazil Viana Junior, Caren Nádia Soares de Sousa, Lia Lira Olivier Sanders   +5 more
wiley   +1 more source

Nationwide Trends in Demographics, Comorbidities, and Mortality Among Elderly Patients with Heart Failure with Preserved Ejection Fraction Hospitalized with Cardiac Arrest. [PDF]

J Pers Med
Mohammed AS, Takagi MA, Yasmeen U, Gandhi A, Khan AFS, Popat A, Desai R, Kambali S, Koshak AKA, Mandoorah S.   +9 more
europepmc   +1 more source

Plasma Ceramide C24:0/C16:0 Relates to Outcomes in Patients With Heart Failure With Preserved Ejection Fraction. [PDF]

JACC Adv
Peterson LR, Gross S, Dörr M, Jiang X, Heurman HC, Friedrich N, Völzke H, Province MA, Cresci S.   +8 more
europepmc   +1 more source

Autoimmune inflammation as a key risk factor for heart failure with preserved ejection fraction: the different types of inflammation driving to HFpEF. [PDF]

Front Med (Lausanne)
Gremese E, Bruno D, Perniola S, Ceolan J, Ferraccioli G.   +4 more
europepmc   +1 more source

Correction to: Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial. [PDF]

Eur Heart J
europepmc   +1 more source

Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction. [PDF]

J Am Heart Assoc
Okada M, Tanaka N, Iwakura K, Onishi T, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Tamaki S, Yasumura Y, Yamada T, Sakamoto D, Hikoso S, Okada K, Nakatani D, Sotomi Y, Sakata Y, OCVC‐Heart Failure Investigators.   +18 more
europepmc   +1 more source

Characterizing Heart Failure with Preserved Ejection Fraction Using Cardiac Magnetic Resonance Diffusion Tensor Imaging

Tasnim F. Imran, Laura Parra, Daniel Arcuri, Wen‐Chih Wu, Michael K. Atalay, Christopher Nguyen, Gaurav Choudhary   +6 more
openalex   +1 more source

Skeletal Muscle Alterations in Different Phenotypes of Heart Failure with Preserved Ejection Fraction. [PDF]

Int J Mol Sci
Vahle B, Klädtke R, Schauer A, Bowen TS, Wisløff U, Linke A, Adams V.   +6 more
europepmc   +1 more source

Cardiac Remodeling and Functional Alterations in Heart Failure With Preserved Ejection Fraction (HFpEF): An Echocardiographic Assessment at a Tertiary Hospital in Bangladesh. [PDF]

Cureus
Rahman MW, Mahmood M, Adhikary DK, Ahmed CM, Hoque MH, Parvin T, Krishna Banerjee S, Khaled MFI.   +7 more
europepmc   +1 more source